Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B

World J Gastroenterol. 2008 Feb 28;14(8):1280-5. doi: 10.3748/wjg.14.1280.

Abstract

Aim: To develop a model using easily obtainable, objective, verifiable preoperative parameters, to help evaluate post transplant survival probability for hepatocellular carcinoma (HCC) patients with hepatitis B.

Methods: We retrospectively examined a cohort of 150 consecutive primary cadaveric liver transplants with HCC in our center over 6 years. Thirteen preoperative biochemical parameters and six tumor-related factors were analyzed to identify their correlation with post transplant survival using the Cox proportional-hazards regression model. The predictive power of a new model and the model for end stage liver disease was compared by the receiver operating characteristic curve.

Results: In univariate analysis, the factors significantly associated with post transplant survival were serum concentrations of albumin, total bilirubin, alkaline phosphatase, alpha-fetoprotein, gamma-glutamyltransferase, aspartate aminotransferase, sodium, tumor diameter and the number of tumor nodules. Multivariate analysis showed alpha-fetoprotein, serum sodium, alkaline phosphatase and the number of tumor nodules were significantly associated with the post transplant outcome. Based on the four variables, we established a new model with a c-statistic of 0.72 which was significantly greater than 0.50 (P = 0.001), and the c-statistic of MELD was 0.59 (P = 0.146).

Conclusion: The new model based on four objective tumor-related parameters has the capacity to evaluate the risk of post transplant mortality for HCC patients with hepatitis B.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Hepatocellular / etiology*
  • Carcinoma, Hepatocellular / mortality
  • Carcinoma, Hepatocellular / therapy*
  • Cell Survival
  • Cohort Studies
  • Female
  • Hepatitis B / complications*
  • Hepatitis B / mortality
  • Hepatitis B / therapy*
  • Humans
  • Liver Diseases / diagnosis
  • Liver Diseases / therapy
  • Liver Neoplasms / etiology*
  • Liver Neoplasms / therapy*
  • Liver Transplantation / methods*
  • Male
  • Middle Aged
  • Proportional Hazards Models
  • Retrospective Studies